Lv3
239 积分 2021-03-06 加入
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer
3个月前
已完结
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study
3个月前
已完结
ZUMA-8: a phase 1 study of brexucabtagene autoleucel in patients with relapsed/refractory chronic lymphocytic leukemia
3个月前
已完结
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer
3个月前
已完结
168 Hours: You Have More Time Than You Think
3个月前
已完结
I Know How She Does It: How Successful Women Make the Most of Their Time
3个月前
已完结
Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma
4个月前
已完结
Development and Use of the Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy Axicabtagene Ciloleucel in Large B-Cell Lymphoma
4个月前
已完结
Progress in the development of cytokine armoured CAR T cells
4个月前
已完结
Made to Stick: Why Some Ideas Survive and Others Die
5个月前
已完结
皖公网安备34019202002308
